Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer

ŞANLI Y., Zukotynski K., Mittra E., Chen D. L., Nadel H., Niederkohr R. D., ...Daha Fazla

CLINICAL NUCLEAR MEDICINE, cilt.43, sa.12, 2018 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 12
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1097/rlu.0000000000002247
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: head and neck cancer, PET, CT, PET, MR, SQUAMOUS-CELL CARCINOMA, POSITRON-EMISSION-TOMOGRAPHY, METABOLIC TUMOR VOLUME, DIFFUSION-WEIGHTED MRI, LYMPH-NODE METASTASES, LOCALLY ADVANCED HEAD, UNKNOWN PRIMARY SITE, FDG PET, F-18-FDG PET/CT, HUMAN-PAPILLOMAVIRUS
  • İstanbul Üniversitesi Adresli: Hayır

Özet

There are recent advances, namely, a standardized method for reporting therapy response (Hopkins criteria), a multicenter prospective cohort study with excellent negative predictive value of F-18-FDG PET/CT for N0 clinical neck, a phase III multicenter randomized controlled study establishing the value of a negative posttherapy F-18-FDG PET/CT for patient management, a phase II randomized controlled study demonstrating radiation dose reduction strategies for human papilloma virus-related disease, and Food and Drug Administration approval of nivolumab for treatment of recurrent head and neck squamous cell carcinoma.